Journal for ImmunoTherapy of Cancer (Nov 2020)

596 Armed myxoma virus demonstrates therapeutic activity in xenograft models

Grant McFadden,
Lina Franco,
Lino Torres-Dominguez,
Mario Abrantes,
Benjamin Walker,
Zachary Tacner,
Cassandra Kien,
Natalie Elliott,
Leslie Sharp,
Anna Waters,
Steven Potts

Affiliations

Grant McFadden: OncMyx Therapeutics, Phoenix, AZ, USA
Lina Franco: OncMyx Therapeutics, Phoenix, AZ, USA
Lino Torres-Dominguez: OncMyx Therapeutics, Phoenix, AZ, USA
Mario Abrantes: OncMyx Therapeutics, Phoenix, AZ, USA
Benjamin Walker: OncMyx Therapeutics, Phoenix, AZ, USA
Zachary Tacner: OncMyx Therapeutics, Phoenix, AZ, USA
Cassandra Kien: OncMyx Therapeutics, Phoenix, AZ, USA
Natalie Elliott: OncMyx Therapeutics, Phoenix, AZ, USA
Leslie Sharp: OncMyx Therapeutics, Phoenix, AZ, USA
Anna Waters: OncMyx Therapeutics, Phoenix, AZ, USA
Steven Potts: OncMyx Therapeutics, Phoenix, AZ, USA

DOI: https://doi.org/10.1136/jitc-2020-SITC2020.0596
Journal volume & issue: Vol. 8, no. Suppl 3

Abstract

No abstracts available.

Published in Journal for ImmunoTherapy of Cancer

ISSN: 2051-1426 (Online)
Publisher: BMJ Publishing Group
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
Website: https://jitc.bmj.com

About the journal